F-Term-List

A61K35/00-35/768;36/06;36/06@Z-36/068

AA00
TYPES OF INVENTIONS

AA01

AA02

AA03

AA04

AA05

AA10

. Inventions for medicinal uses and methods for manufacturing medicines mentioned in claims

. Experimental data with medicinal uses or pharmaceutical applications

. Substances with characteristic manufacturing methods

. . Isolation and extraction methods

. . Refining methods

. Others *

BA00
DERIVATION OF ACTIVE SUBSTANCES FROM INANIMATE OBJECTS

BA01

BA02

BA03

BA04

BA05

BA06

BA07

BA10

. Water

. Stones, rocks, soil, minerals, or clay minerals

. Tar, bitumen, bitumen derivatives, or mineral oils

. . Ichthammol

. . Mineral oils

. Mineral springs, e.g., hot springs

. Peat, coal, or amber

. Others *

BB00
DERIVATION OF ACTIVE SUBSTANCES FROM ANIMALS

BB01

BB02

BB03

BB04

BB05

BB06

BB07

BB08

BB09

BB10

. Protozoa or Mesozoa, e.g., amoebas

. Porifera, e.g., sea sponges

. Coelenterata

. . Thecata or Cnidaria, e.g., coral

. . Acnidaria, i.e., pectinate animals such as medusa

. Platyhelminthes, Nemertinea, or Chaetognatha, e.g., Clonorchis

. Nematoda or Nemathelminthes, e.g., Enterobius

. Rotifera or Trochelmithes, e.g., Rotatoria

. Annelida

. . Polychaeta, e.g., Neanthes

BB11

BB12

BB13

BB14

BB15

BB16

BB17

BB18

BB19

BB20

. . Oligochaeta, e.g., Pheretima

. . Hirudinea, e.g., leeches

. Mollusca or Molluscoidea

. . Gastropoda, e.g., Aplysiidae

. . Cephalopoda, e.g., ammonites

. . Bivalves or bivalvia, e.g., Pinctada

. Arthropoda

. . Chelicerae, e.g., limuli

. . Mandibulata, e.g., daphnias

. . . Malacostraca, e.g., Euphausia

BB21

BB22

BB23

BB24

BB25

BB26

BB27

BB28

BB29

BB30

. . . Insecta, e.g., Odonata

. . . . Hymenoptera, e.g., Apis

. Echinodermata

. . Holothuroidea

. . Echinoidea

. . Asteroidea

. Prochordata, e.g., sea squirts

. Vertebrata

. . Pisces

. . . Liver oil

BB31

BB32

BB33

BB34

BB35

BB36

BB37

BB38

BB39

BB40

. . Amphibia, e.g., frogs and newts

. . Reptilia, e.g., snakes and lizards

. . Mammalia or Aves

. . . Blood

. . . . Blood plasma and blood serum

. . . . Red blood corpuscles

. . . . White blood corpuscles

. . . . Blood platelets

. . . Milk, colostrum, or mature milk

. . . Urine or urinary organs

BB41

BB42

BB43

BB44

BB45

BB46

BB47

BB48

BB49

BB50

. . . . Kidneys

. . . Mucilage, mucous-gland bursae, synovia, gland secretory fluids, spinal fluid, or thymus

. . . Lymphatic fluid or lymphatic glands

. . . Bone marrow or spleen

. . . Nerves or brain

. . . Bones, tendons, teeth, or cartilage

. . . Muscles or heart

. . . Skin, hair, nails, sebaceous glands, or earwax

. . . Digestive organs

. . . . Stomach or intestines, e.g., duodenum, small intestine, large intestine, caecum, colon, or rectum

BB51

BB52

BB53

BB54

BB55

BB56

BB57

BB58

BB59

BB60

. . . . Pancreas

. . . . Liver

. . . . Bile, i.e., bile acids or bile pigments

. . . . Saliva or salivary glands

. . . Lungs

. . . Eyes

. . . Sex organs or embryos

. . . . Placenta or amniotic fluid

. . . . Umbilical cords

. . . . Semen

BB61

BB62

BB63

BB64

BB65

BB70

. . . . Uterus, vagina, or eggs

. . . Other body fluids or glands

. . . Tissues or cells

. . . . Cultured tissues or cells

. . . . Gene-splicing cells

. Others *

BC00
DERIVATION OF ACTIVE SUBSTANCES FROM MICRO-ORGANISMS

BC01

BC02

BC03

BC04

BC05

BC06

BC07

BC08

BC09

BC10

. Eumycetes

. . Zygomycetes

. . Basidiomycetes, e.g., mushrooms

. . Deuteromycetes

. . . Hyphomycetes, e.g., molds

. . . . Aspergillus

. . . . Penicillium

. . . . Fusarium

. . . . Trichoderma

. . . . Monascus

BC11

BC12

BC13

BC14

BC15

BC16

BC17

BC18

BC19

BC20

. . . Yeasts

. . . . Saccharomyces

. . . . Candida

. . . . Torula or Pichia

. Actinomycetes

. . Nocardia

. . Rhodococcus

. . Pseudonocardia

. . Actinoplanes

. . Dactylosporangium

BC21

BC22

BC23

BC24

BC25

BC26

BC27

BC28

BC29

BC30

. . Micromonospora

. . Streptomyces, i.e., undefined species

. . . Streptomyces with a specific species name

. . Actinosporangium

. . Streptoverticillium

. . Actinomadura

. . Streptosporangium

. . Actinomyces or Excellospora

. . Mycobacterium

. Bacteria or germs

BC31

BC32

BC33

BC34

BC35

BC36

BC37

BC38

BC39

BC40

. . Gram-negative bacilli or cocci

. . . Enterobacteriacea

. . . . Escherichia

. . . . . Escherichia coli, i.e., coliform bacteria

. . . . Salmonella

. . . . Klebsiella

. . . . Serratia

. . . . Shigella or Citrobacter

. . . . Proteus or Erwinia

. . . Pseudomonadaceae

BC41

BC42

BC43

BC44

BC45

BC46

BC47

BC48

BC49

BC50

. . . . Pseudomonas aeruginosa

. . . . Pseudomonas fluorescens

. . . Vibrionaceae

. . . Pasteurellaceae

. . . Acetobacteraceae

. . . Azotobacteracea

. . . Rhizobiaceae

. . . Halobacteriaceae

. . . Methylococcaceae

. . . Neisseriaceae

BC51

BC52

BC53

BC54

BC55

BC56

BC57

BC58

BC59

BC60

. . . Bordetella or Altermonas

. . . Alcaligenes or flavobacteria

. . . Bacteroidaceae

. . Other gram-negative fungus

. . Gram-positive bacilli or cocci

. . . Lactobacilli

. . . . Lactobacillus casei

. . . . Lactobacillus acidophilus

. . . Bifidobacteria

. . . . Bifidobacterium bifidum

BC61

BC62

BC63

BC64

BC65

BC66

BC67

BC68

BC69

BC70

. . . Streptococci

. . . . Streptococcus faecalis

. . . . Streptococcus pyogenes

. . . Bacilli

. . . . Bacillus subtilis

. . . . Bacillus cereus

. . . . Bacillus megaterium

. . . Clostridium

. . . . Clostridium butyricum

. . . Micrococcaceae

BC71

BC72

BC73

BC74

BC75

BC76

BC77

BC78

BC79

BC80

. . . . Staphylococcus aureus

. . . Corynebacteria and Brevibacteria

. . . . Corynebacterium diphtheriae

. . . Propionibacteria

. . . Leuconostoc or Peptostreptococci

. . . Listeria

. . . Arthrobacter or Eubacteria

. . Gliding bacteria

. . . Cytophagaceae

. . Photosynthetic bacteria

BC81

BC82

BC83

BC84

BC90

. . Spirochetes or rickettsiae

. . Mycoplasmataceae

. Viruses

. Modified bacteria

. Others *

CA00
SUBSTANCES WITH CHARACTERISTIC FUNCTIONS

CA01

CA02

CA03

CA04

CA05

CA06

CA07

CA08

CA09

CA10

. Inorganic active substances

. Organic active substances

. . Animal materials

. . . Animal cells or cultures

. . . Receptors, cell factors, or activating factors

. . . Extracts

. . . Dairy products

. . Microorganisms or microbial materials

. . . Use of fungi, i.e., entire fungus or partial fungus

. . . Cultures, culture filtrates, or metabolites

CA11

CA12

CA13

CA14

CA15

CA16

CA17

CA18

CA19

CA20

. . . Extracts

. . Genes, gene deoxyribonucleic acid (DNA), vectors, or recombinant living bodies

. . Macromolecular substances which constitute organisms

. . . Sugars

. . . . Liposaccharides

. . . Proteins, i.e., peptides

. . . . Glycoproteins

. . . . Lipoproteins

. . . Lipids, i.e., fats or oils

. . . Macromolecular substances except nucleic acids (i.e., nucleosides) and gene deoxyribonucleic acid (DNA)

CA21

CA22

CA23

CA24

CA25

CA26

CA27

CA28

CA29

CA30

. . . Mixtures of blood and blood components

. . Substances with defined property data and chemical structures

. . . Compounds with specific molecular weights (MW)

. . . . Molecular weights that are less than or equal to 250

. . . . Molecular weights that are greater than 250 and less than or equal to 500

. . . . Molecular weights that are greater than 500 and less than or equal to 750

. . . . Molecular weights that are greater than 750 and less than or equal to 1000

. . . . Molecular weights that are greater than 1000 and less than or equal to 1500

. . . . Molecular weights that are greater than 1500 and less than or equal to 2500

. . . . Molecular weights that are greater than 2500 and less than or equal to 5000

CA31

CA32

CA33

CA34

CA36

CA37

CA38

CA39

CA40

. . . . Molecular weights that are greater than 5000 and less than or equal to 10000

. . . . Molecular weights that are greater than 10000 and less than or equal to 50000

. . . . Molecular weights that are greater than 50000 and less than or equal to 100000

. . . . Molecular weights that are greater than 100000

. . . Compounds with defined molecular formulas and overall chemical structures

. . . . Constituents that contain carbon (C), hydrogen (H), and oxygen (O)

. . . . Constituents that contain carbon (C), hydrogen (H), oxygen (O), and nitrogen (N)

. . . . Constituents that contain carbon (C), hydrogen (H), oxygen (O), and sulfur (S)

. . . . Constituents that contain carbon (C), hydrogen (H), oxygen (O), nitrogen (N), and sulfur (S)

CA41

CA42

CA43

CA44

CA45

CA46

CA47

CA50

. . . . Constituents that contain carbon (C), hydrogen (H), and nitrogen (N) or carbon (C), hydrogen (H), and sulfur (S)

. . . . Constituents which contain halogens

. . . . Constituents which contain phosphorous or metals

. . . . Constituent amino acids for which the sequence or composition is defined

. . . . . Specification of types of constituent amino acids only

. . . . . Variants wherein the number of amino acid residue in the sequence is 50 or less

. . Undefined property data

. Others *

DA00
TREATMENT OF BLOOD AND BLOOD COMPONENTS

DA01

DA02

DA03

DA04

DA05

DA06

DA07

DA08

DA09

DA10

. Characteristics of technical improvements

. . Improvements related to treatment materials

. . Improvements related to treatment methods

. . Improvements related to treatment devices, apparatuses, or treatment systems

. Purification of blood or blood components

. . Removal and inactivation of viruses or virus antigens

. . Removal of hazardous metals, detrimental cells, or immunity inhibitors

. . Sterilization and detoxification

. . Bleaching

. Preservation of blood or blood components

DA11

DA12

DA14

DA15

DA16

DA17

DA18

DA19

DA20

. . Preservation by use of hemolysis inhibitors

. . Preservation by frozen storage or thawing methods

. Separation of blood components from blood, i.e., isolation

. . Separation of blood plasma or blood serum

. . Separation of corpuscles

. . . Separation of red blood corpuscles

. . . Separation of white blood corpuscles

. . . . Separation of granules and single cells

. . . . Separation of lymphocytes

DA21

DA22

DA23

DA24

DA25

DA26

DA27

DA28

. . . Separation of blood platelets

. . Separation of macromolecules

. . . Blood-coagulation factors

. . . Factors inhibiting blood coagulation

. . . Adjustment factors of corpuscle composition or corpuscle decomposition

. . . Proteins, apoproteins, or globulins

. . . Substances for cell stimulation, or factors affecting cell multiplication or cell adjustment

. . . Separation or preparation of substances similar to human blood components

DA31

DA32

DA40

. Cell activation methods

. . Cell activation by agents which induce stimulation

. Others *

MA00
COMPOUNDING AGENT, DOSAGE FORM, OR APPLICABLE SITE

MA01

MA02

MA05

. Compounding agent

. . Agents containing two or more types of active components

. . Agents with characteristic inactive components

MA11

MA12

MA13

MA16

MA17

. Dosage form

. . Gaseous

. . . Aerosol or foamed agents

. . Liquid

. . . Solutions, e.g. aqueous solution or non-aqueous solution

MA21

MA22

MA23

MA24

MA27

MA28

. . . Liquid dispersion agents

. . . . Emulsion

. . . . Syrup or suspension

. . . . Ribosome

. . Semi-solids

. . . Creams, pastes, or ointments

MA31

MA32

MA34

MA35

MA36

MA37

MA38

. . . Suppositories or bougies

. . . Pasting agents

. . Solids

. . . Pills or buccals

. . . Pellets

. . . Capsules

. . . . Micro-capsules

MA41

MA43

MA44

MA47

. . . Granular agents

. . . Powdered agents

. . . . Freeze-dried powder

. . . Gums

MA51

MA52

MA55

MA56

MA57

MA58

MA59

MA60

. Application sites

. . Oral

. . Non-oral

. . . Body cavity or mucous membrane

. . . . Oral cavity

. . . . Eyes

. . . . Nasal cavity

. . . . Rectum

MA63

MA65

MA66

MA67

MA70

. . . Skin or skin exterior

. . . Blood vessel or tissue interior

. . . . Injection, infusion, or intravenous drip

. . . . Internal embedding

. Others (*)

NA00
PURPOSE OR EFFECT OF COMPOUND PER SE, COMPOUNDING, OR FORMULATION

NA01

NA02

NA03

NA04

NA05

NA06

NA07

NA08

NA09

NA10

. Virus attenuation

. Solubilization

. Stabilization

. Preparations upon use

. Improvement of work reinforcement or selectivity

. Reduction of side reactions

. Toxicity reduction

. Painlessness

. Correction of taste or odor

. Change of dosing mode

NA11

NA12

NA13

NA14

NA15

NA20

. Improvement of absorption

. Gradual release or effectiveness of the release time

. Drug delivery system (DDS)

. Expression of new medicinal effects

. Pro-drugs

. Others (*)

ZA00
MEDICINAL USE OR TARGET ORGAN

ZA01

ZA02

ZA03

ZA04

ZA05

ZA06

ZA07

ZA08

. Medicines working on nervous system

. . Drugs working on central nervous system

. . . Central nervous system inhibitors

. . . . General anesthetics

. . . . Hypnotics or sedatives

. . . . Anti-epilepsy agents

. . . . Antipyretic agents

. . . . Pain-killers

ZA11

ZA12

ZA14

ZA15

ZA16

ZA18

ZA20

. . . Central nervous stimulants

. . . . Anti-depression agents

. . . Anti-motion-sickness agents

. . . Agents for improvement of brain function

. . . . Agents for Alzheimer's disease

. . . Anti psychoneurosis agents

. . Drugs for peripheral nerves

ZA21

ZA22

ZA23

ZA24

ZA25

ZA26

ZA27

ZA28

ZA29

ZA30

. . . Sensory nerve agents

. . . Motor nerve agents

. . . . Skeletal muscle relaxants

. . . Autonomic nerve agents

. . . . Sympathetic nerve stimulants

. . . . Sympathetic nerve inhibitors

. . . . Parasympathetic nerve stimulants

. . . . Parasympathetic nerve depressants

. . . . Anti-spasmodics

. . . . Diaphoretic or agents for stopping perspiration

ZA31

ZA32

ZA33

ZA34

ZA36

ZA37

ZA38

ZA39

ZA40

. Medicines having effects on each organ

. . Drugs for sensory organs

. . . Ophthalmic agents

. . . Otorhinology agents

. . Drugs for circulatory organs

. . . Myocardium stimulants

. . . Myocardium inhibitors

. . . Blood vessel vasodilators

. . . . Coronary blood vessel vasodilators

ZA41

ZA42

ZA43

ZA44

ZA45

. . . Blood vessel vasoconstrictors

. . . Blood pressure hypotensive agents

. . . Vasopressors

. . . Blood vessel reinforcing agents

. . . Agents for treating arteriosclerosis

ZA51

ZA52

ZA53

ZA54

ZA55

ZA59

ZA60

. . Drugs for hematogenous organs, bone marrow, blood or humor

. . . Substitute blood

. . . Haemostatic and blood coagulation agents

. . . Anti-blood coagulation agents and thrombolytic agents

. . . Anti-anemia agents

. . Drugs for respiratory organs

. . . Breathing accelerators

ZA61

ZA62

ZA63

ZA66

ZA67

ZA68

ZA69

ZA70

. . . Bronchus vasodilators

. . . Antitussives

. . . Phlegm remover

. . Drugs for digestive organs

. . . Dentistry oral cavity agents

. . . Digestive ulcer agents

. . . Peptic digestive agents

. . . Anti-obesity agents

ZA71

ZA72

ZA73

ZA75

ZA76

ZA77

. . . Sedative for vomitory and vomitous agents

. . . Purgative agents

. . . Intestinal regulators

. . . Agents for liver or bile duct disorders

. . . Biliary agents

. . . . Litholytics

ZA81

ZA82

ZA83

ZA84

ZA85

ZA86

ZA89

ZA90

. . Drugs for urinogenital organs or anus

. . . Urine vessel bactericide

. . . Diuretics

. . . Anti-diuretics

. . . Womb contractile agents

. . . Birth control pills

. . Outer skin drugs

. . . Sanitiser for outer skin

ZA91

ZA92

ZA94

ZA96

ZA97

. . . Skin softener

. . . Agents for head skin or hair

. . Drugs for the muscular system

. . Drugs for the skeletal system

. . . Agents for osteoporosis

ZB00
MEDICINAL USE OR BIOLOGICAL DEFENSE

ZB01

ZB02

ZB03

ZB05

ZB07

ZB08

ZB09

. Medicines specified by their effects for biophylactic mechanisms.

. . Drugs for cellular immunity system

. . . Interferon-inducing agents

. . Drugs for humoral immune mechanisms, i.e. antibody production

. . Drugs for immunity adjustments

. . Immunity inhibitors

. . Immunity accelerators

ZB11

ZB13

ZB15

. . Inflammation drugs

. . Anti-allergic drugs

. . Anti-rheumatic drugs

ZB21

ZB22

ZB26

ZB27

. Medicines having effects on tissue cellular functions

. . Drugs for activating cells

. . Medicines for tumors

. . . Anti-leukemia agents

ZB31

ZB32

ZB33

ZB35

ZB37

ZB38

ZB39

. Medicines having effects on pathogenic organisms

. . Drugs for pathogenic microorganisms

. . . Anti-viral agents

. . . Antibacterial agents

. . Drugs for parasites

. . . Anti-protozoan agents

. . . Vermicides

ZC00
MEDICINAL USE, FUNCTION, MECHANISM, TARGET, OR OTHERS

ZC01

ZC02

ZC03

ZC04

ZC06

ZC08

ZC10

. Medicines specified based on the effects on vital functions

. . In vivo physiologically active substance-like drugs

. . . Hormone-like agents

. . . . Pituitary hormone-like agents

. . . . Thyroid, parathyroid hormone-like agents

. . . . Paranephros hormone-like agents

. . . . Male hormone-like agents

ZC11

ZC12

ZC13

ZC14

ZC16

ZC17

ZC19

ZC20

. . . . Female hormone-like agents

. . . . Prostaglandins-like agents

. . . Antihistamins

. . . Antiserotonin agents

. . . Bradykinin-like agents

. . . Angiotensin-like agents

. . . Enzyme activators, i.e. agents for activating enzyme activity

. . . Enzyme inhibitors

ZC21

ZC22

ZC23

ZC24

ZC25

ZC26

ZC28

ZC29

. . Drugs for metabolic pathways

. . . Vitamin-like agents

. . . . Vitamin A- or D-like agents

. . . . Vitamin B-like agents

. . . . . Vitamin B1-like agents

. . . . . Vitamin B2-like agents

. . . . Vitamin C- or P-like agents

. . . . Vitamin E- or K-like agents

ZC31

ZC33

ZC35

ZC37

ZC39

. . . Agents for uric acid metabolic pathway

. . . Lipid metabolic system agents

. . . Carbohydrate metabolic system agents

. . . Detoxicants

. . . Agents for habit-forming toxication

ZC41

ZC42

ZC43

ZC44

ZC45

ZC48

ZC50

. Medicines specified by mechanisms thereof

. . Receptor antagonists (*)

. . . Beta blocker

. . . Histamine H2 blocker

. . . Histamine H1 blocker

. . Anti-platelet activation factors (PAF) drugs

. . Calcium antagonists

ZC51

ZC52

ZC54

ZC55

. Medicines specified by treatment subjects

. . Drugs for geriatric disease

. . Specified drugs by symptoms or names of diseases (*)

. . . Agents for acquired immune deficiency syndrome (AIDS)

ZC61

ZC62

ZC63

ZC64

ZC65

. . Drugs for animals

. . . Udder-inflammation agents

. . . Milk-inducing agents

. . . Agents for coccidiosis

. . . Agents for poikilothermal animals

ZC71

ZC72

ZC75

ZC78

ZC80

. Medicines related to physical therapy

. . Drugs for moxibusion therapy

. Synergistic medicines

. Analysis and detection reagents

. Others or unidentified (*)

4C087	MEDICINES CONTAINING MATERIAL FROM ANIMALS OR MICRO-ORGANISMS
	A61K35/00 -35/768;36/06;36/06@Z-36/068